19
OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah- Hebrew University Medical Center, Jerusalem, Israel Authors have no financial interests in any of the mentioned products or companies

OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Embed Size (px)

Citation preview

Page 1: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY

F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon,

Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Authors have no financial interests in any of the mentioned products or companies

Page 2: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Glaucoma is one of the most frequent and severe

postoperative complications of penetrating keratoplasty

loss of endothelial cells → graft failure

Increased IOP

optic nerve damage → visual loss

Page 3: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Incidence of glaucoma after penetrating keratoplasty

Karesh JW, Am J Ophthalmol 96:160,1983

Thoft RA, Trans Am Acad Ophthalmol 1974;78:352-65

7,3%-33,6%

Page 4: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

PURPOSE

This study evaluated the incidence and risk factors associated with Ocular Hypertension following penetrating keratoplasty

Page 5: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Patient Characteristics

Number of patients 146Age (years) 45 ± 20.8 ( 15 – 88)Sex Male 71(48.6%) Female 75(51.4%)

IOP (mm Hg) Mean ± SD 13.2 ± 3.7 Range 5-26 High IOP (n) 6(4.1%)

Follow-up 24.4±7.5 (12-41 mo.)

Page 6: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Pre-op antiglaucoma medications 33 (22.6%) pts.

1 medication 23 pts. 2 medications 7 pts. 3 medications 3 pts.

s/p trabeculectomy in 8 pts

Glaucoma Prior to PKP

Page 7: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Other

Perforation

Fuchs dyst.

Scar-HSK

Trauma

Dystrophies

BK(other)

Corn.scar

PBK

FG

KCN

KCN: 60(41.1%)

FG: 30(20.5%)

PBK: 19(13%)

SCAR: 12(8.2%)

TRAU: 6(4.1%)

HSK: 4(2.7%)

DISTR: 3(2.1%)

BK(other):3(2.1%

FUCH: 3(2.1%)

PERF: 2(1.4%)

ASTIG 1(0.7%)

ULC: 1(0.7%)

INT.KR:1(0.7%)

DIAGNOSIS

Page 8: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Previous ocular surgery (n=70)

Previous surgery Number Percentage

Cataract extraction 22 (15.1)PKP 20 (13.7)Triple procedure 10 (6.8)Trauma, Perforation repair 3 (2.1)Trabeculectomy + ECCE + PKP 3 (2.1)Trabeculectomy + PKP 2 (14)Trabeculectomy + ECCE 2 (1.4)Stem cell transplantation+AMT 2 (1.4)Trabeculectomy 1 (0.7)Vitrectomy + ECCE + PKP 1 (0.7)Retina detachment repair + Vitrectomy 1 (0.7)Retina detachment repair + cataract surgery 1 (0.7)LKP 1 (0.7)PRK 1 (0.7) Total 70 47.9

Page 9: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Size of graft: Mean 8.0 mm Range 7.0-9.0 mm

Oversize 0.25mm 0.50mm 134 pts. 16pts.

Sutures Interrupted 110 (76.1%) pts. Continuous 36 (23.9%) pts.

Page 10: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

AD

DIT

ION

AL P

RO

CE

DU

RE

S

n=

21(1

4.4

%)

Triple proced

AC IOL ex+vitrectomy

ACIOL ex

Vitrectomy

AC IOL remov

number of eyes

1086420

1

3

3

6

8

Combined Procedures (with PKP) N=21 (14.4%)

Page 11: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Post-PKP Complications 30(20.5%)

pts.(%)Rejection 10 (6.8%)Failed Grafts 13 (8.9%)

Non-Healing ED 8 (5.5%) Infection 5 (3.4%)

Recurrent HSK 2 (1.4%)

Page 12: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Mean 27.1± 5.7mmHg (21-49mmHg)

Starting - 70.3 days after PKP Lasting - 15.6±16.8 days

Topical steroids n=69

Ocular Hypertension after PKP n=70 pts. (47.9%)

Page 13: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Ocular Hypertension after PKP

Hx of Preexisting Glaucoma New Glaucoma PN 25 45PostPKP IOP(mmHg) 29.7± 7.0 25.7±4.2 0.02 Starting Time(days) 39.2 ±57.4 87.6±157.6 0.014N. of Medications 1.5±0.7 1.1±0.36 0.001

Page 14: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Treatment pts. (%)

1 medication 47 (69.1%)2 medications 12 (17.6%) 3 medications 3 (4.4%)

Not responsive to anti-glaucoma treatment n=11(7.5%)

Glaucoma surgery n=3

Second Episode of High IOP n=35

Ocular Hypertension after PKP

Page 15: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Graft Failure in Patients with Postperative Glaucoma

• 9 of 13 failed grafts (P=0.107).

• Pre-existing glaucoma was not a cause for graft failure (p=0.152 chi-square test)

Page 16: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Significant Risk Factors

for Ocular Hypertension after PKP(Univariate analysis *)

Risk Factors P Value

Preexisting glaucoma p<0.001Previous ocular surgery p=0.011Donor oversize 0.50mm p=0.003Additional intraocular surgery p<0.001Pseudophakia, Aphakia p=0.001

*Chi-Square test

Page 17: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Multivariate Analysis

Preexisting glaucoma p=0.009

Previous ocular surgery p=0.86

Donor oversize 0.50mm p=0.07

Additional intraocular surgery p=0.007Pseudophakia,Aphakia p=0.729

Page 18: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Conclusions

• Ocular Hypertension is Common in Patients Post-PKP

• Pre-Operative Glaucoma and Additional Surgical Procedures are risk factors for Postoperative Ocular Hypertension

• Monitoring of IOP During all Visits after PKP

Page 19: OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew

Summary

The incidence of one episode of ocular

hypertension after PKP is 47.7%Starting after 70 days

Second episode: 24%

7.5% do not respond to topical management